Explore our comprehensive collection of articles and resources about children's health, development, and well-being.
This article introduces Child APL: t(15;17) causes PML-RARα fusion; treated with ATRA/arsenic; high bleeding risk; >90% survival.
This article introduces Child APL: t(15;17) causes PML-RARα fusion; treated with ATRA/arsenic; high bleeding risk; >90% survival.
Acute promyelocytic leukemia in children